Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM) Proceeding/Conference:Journal of Clinical Oncology | 2010 | ||
Combination chemotherapy with sunitinib (IND 74019; NSC 736511) for untreated extensive-stage small cell lung cancer (SCLC): CALGB 30504 phase IB safety results Proceeding/Conference:Journal of Clinical Oncology | 2010 | ||
Comparison of chemoradiotherapy treatment strategies in stage III non-small cell lung cancer among elderly patients from multiple data sources Proceeding/Conference:Annals of Oncology | 2017 | ||
An Interim Report Of CALGB 150607: Expression And Mutational Status Of c-MET, HGF, EGFR, KRAS, p53, c-CBL, And E-cadherin In Resected Lung Adenocarcinoma Specimens Proceeding/Conference:Journal of Thoracic Oncology | 2012 |